NCT06218199View on ClinicalTrials.gov

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Heart Failure, Congestive
Interventions
DRUG

Furosemide

oral administration

DRUG

Torsemide

oral administration

DRUG

Bumetanide

oral administration

DRUG

sacubitril/valsartan

oral administration

DRUG

Hydralazine

oral administration

DRUG

Isosorbide Dinitrate

oral administration

Trial Locations (1)

35801

RECRUITING

Heart Center Research, LLC, Huntsville

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Heart Center Research, LLC

NETWORK

NCT06218199 - Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts | Biotech Hunter | Biotech Hunter